✦ LIBER ✦

CCN3: a key growth regulator in Chronic Myeloid Leukaemia

✍ Scribed by Lynn McCallum; Wanhua Lu; Susan Price; Noureddine Lazar; Bernard Perbal; Alexandra E. Irvine

Book ID: 107594198
Publisher: Springer Netherlands
Year: 2009
Tongue: English
Weight: 442 KB
Volume: 3
Category: Article
ISSN: 1873-9601
DOI: 10.1007/s12079-009-0058-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CCN3 suppresses mitogenic signalling and

CCN3 suppresses mitogenic signalling and reinstates growth control mechanisms in Chronic Myeloid Leukaemia

✍ Lynn McCallum; Wanhua Lu; Susan Price; Noureddine Lazar; Bernard Perbal; Alexand 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 881 KB

Chronic myeloid leukaemia in a haemophil

Chronic myeloid leukaemia in a haemophiliac

✍ Ghosh, K. ;Deshpande, A. S. ;Mohanty, D. ;Das, K. C. 📂 Article 📅 1987 🏛 Springer-Verlag ⚖ 127 KB

Red cell membrane abnormalities in chron

Red cell membrane abnormalities in chronic myeloid leukaemia

✍ Kumar, A.; Gupta, C. M. 📂 Article 📅 1983 🏛 Nature Publishing Group 🌐 English ⚖ 231 KB

Dasatinib-induced response in a rare cas

Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia

✍ Cristina Tecchio; Ilaria Nichele; Giuseppe Todeschini; Giovanni Pizzolo; Achille 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

A Possible Specific Chromosome Abnormali

A Possible Specific Chromosome Abnormality in Human Chronic Myeloid Leukæmia

✍ BAIKIE, A. G.; COURT-BROWN, W. M.; BUCKTON, KARIN E.; HARNDEN, D. G.; JACOBS, PA 📂 Article 📅 1960 🏛 Nature Publishing Group 🌐 English ⚖ 246 KB

CD7 expression on CD34+ cells from chron

CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase

✍ Mart�n-Henao, G.A.; Quiroga, R.; Sureda, A.; Garc�a, J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Thirty-seven patients with chronic phase chronic myeloid leukaemia and fourteen healthy controls have been evaluated for lineage differentiation with immunological markers on purified bone marrow CD34 positive cells by multiparameter flow cytometry. The myeloidassociated antigen CD33 and the stem ce